about
Prognostic and predictive value of PDL1 expression in breast cancer.Comparative genomic analysis of primary tumors and metastases in breast cancer.Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.Epigenetically centered evolution in an example of myeloid malignancy.Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolutionA Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signaturesAuthor Correction: Genomic characterization of metastatic breast cancersNOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancersTargeted molecular characterization shows differences between primary and secondary myelofibrosisGenomic characterization of metastatic breast cancersSLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbationsPublisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbationsAuthor Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations
P50
Q35741710-79ACBBCD-1CA3-4480-9EE9-7A811C977B65Q37317214-8848C00B-DBB0-41FA-8B23-D01BF0536C33Q37694797-CB35CE45-F3D0-40F9-AA55-D5DDA63569B2Q41177344-00BE8DF6-8D3D-4612-BBC1-10942AB03F73Q42334362-083AD7D9-77CC-4CF1-A5A3-A117C8B694A2Q43155337-21B9562D-1578-4947-8319-C3BD6DD232F7Q47181311-2333E662-6D8B-413D-AF45-548972CDE6F4Q49375219-6D6FEFE5-8D94-4689-A2DE-36D2E47C53C1Q53084522-0A5DFBCF-C637-4C2D-87AA-CAEFD95F2B2EQ53412376-412051EF-1F4F-46A4-8882-4B988519EB5BQ58612860-9FF34A5B-51A4-4408-AA9F-FC114BF184B8Q64882389-2415F3E2-73B0-49E6-B826-99571311B430Q89467972-BD2586E2-8224-4C3E-B6D3-8227A52B8B05Q91904903-E7F46DB2-07E2-44F0-9F2B-2C06CD37A4B6Q92107432-9BF1A4BE-FF64-4D93-85D0-37C837F095D6Q92147394-793FF6B0-73FC-46BB-9EFB-25B699640E05Q92227242-714DFC34-C529-4F54-BFE7-26242AF51D85Q94600564-AC1B72EC-D636-4124-BEF3-C47BC6E6F030Q94686799-1E30164A-BC95-4201-9821-BD96B07A472BQ94686806-9A8EC100-A8E1-4A9A-8995-C10197C8A2B4
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Max Chaffanet
@en
Max Chaffanet
@nl
type
label
Max Chaffanet
@en
Max Chaffanet
@nl
prefLabel
Max Chaffanet
@en
Max Chaffanet
@nl
P31
P496
0000-0002-2344-1488